A Regulator of Procaspase-1 Activation Is Containing a Caspase
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Golgi Phosphoprotein 3 Promotes the Proliferation of Gallbladder Carcinoma Cells Via Regulation of the NLRP3 Inflammasome
ONCOLOGY REPORTS 45: 113, 2021 Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome ZHENCHENG ZHU1,2*, QINGZHOU ZHU1,2*, DONGPING CAI3, LIANG CHEN4, WEIXUAN XIE2, YANG BAI2 and KUNLUN LUO1,2 1Anhui Medical University, Hefei, Anhui 230032; Departments of 2Hepatobiliary Surgery, 3Laboratory and 4Cardiology, The 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, Jiangsu 214044, P.R. China Received January 18, 2021; Accepted April 2, 2021 DOI: 10.3892/or.2021.8064 Abstract. Golgi phosphoprotein 3 (GOLPH3) has been Introduction demonstrated to promote tumor progression in various gastro‑ intestinal malignancies. However, its effects in gallbladder Gallbladder carcinoma (GBC) is a highly malignant tumor carcinoma (GBC) remain unknown. In the present study, the of the biliary system with a median survival time of only expression levels of GOLPH3 and nucleotide‑binding domain 6 months (1‑3). The primary pathological type of GBC leucine‑rich repeat and pyrin domain containing receptor 3 observed in patients is adenocarcinoma. The effects of current (NLRP3) in human GBC tissues were detected by immuno‑ chemotherapeutic regimens are not sufficient for GBC due histochemistry, and the clinical data and survival of these to the lack of effective drugs, making it particularly difficult patients were analyzed. Next, whether GOLPH3 could affect to control the mortality rate of GBC (3,4). Due to the close tumor proliferation via regulation of the NLRP3 inflamma‑ relationship between inflammation and GBC, investigation of some was investigated in vitro. The results demonstrated that inflammatory‑related molecular mechanisms may highlight GOLPH3 could promote GBC cell proliferation, and that it novel specific targets for the treatment of GBC (4). -
Bacillus Anthracis
The FIIND domain of Nlrp1b promotes oligomerization and pro-caspase-1 activation in response to lethal toxin of Bacillus anthracis by Vineet Joag A thesis submitted in conformity with the requirements for the degree of Masters of Science Graduate Department of Laboratory Medicine and Pathobiology University of Toronto ©Copyright by Vineet Joag (2010) The FIIND domain of Nlrp1b promotes oligomerization and pro- caspase-1 activation in response to lethal toxin of Bacillus anthracis Vineet Joag Masters of Science Laboratory Medicine and Pathobiology University of Toronto 2010 Abstract Lethal toxin (LeTx) of Bacillus anthracis kills murine macrophages in a caspase-1 and Nod-like- receptor-protein 1b (Nlrp1b)-dependent manner. Nlrp1b detects intoxication, and self-associates to form a macromolecular complex called the inflammasome, which activates the pro-caspase-1 zymogen. I heterologously reconstituted the Nlrp1b inflammasome in human fibroblasts to characterize the role of the FIIND domain of Nlrp1b in pro-caspase-1 activation. Amino-terminal truncation analysis of Nlrp1b revealed that Nlrp1b1100-1233, containing the CARD domain and amino-terminal 42 amino acids within the FIIND domain was the minimal region that self- associated and activated pro-caspase-1. Residues 1100EIKLQIK1106 within the FIIND domain were critical for self-association and pro-caspase-1 activation potential of Nlrp1b1100-1233, but not for binding to pro-caspase-1. Furthermore, residues 1100EIKLQIK1106 were critical for cell death and pro-caspase-1 activation potential of full-length Nlrp1b upon intoxication. These data suggest that after Nlrp1b senses intoxication, the FIIND domain promotes self-association of Nlrp1b, which activates pro-caspase-1 zymogen due to induced pro-caspase-1 proximity. -
Role of NLRP3 Inflammasome Activation in Obesity-Mediated
International Journal of Environmental Research and Public Health Review Role of NLRP3 Inflammasome Activation in Obesity-Mediated Metabolic Disorders Kaiser Wani , Hind AlHarthi, Amani Alghamdi , Shaun Sabico and Nasser M. Al-Daghri * Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia; [email protected] (K.W.); [email protected] (H.A.); [email protected] (A.A.); [email protected] (S.S.) * Correspondence: [email protected]; Tel.: +966-14675939 Abstract: NLRP3 inflammasome is one of the multimeric protein complexes of the nucleotide-binding domain, leucine-rich repeat (NLR)-containing pyrin and HIN domain family (PYHIN). When ac- tivated, NLRP3 inflammasome triggers the release of pro-inflammatory interleukins (IL)-1β and IL-18, an essential step in innate immune response; however, defective checkpoints in inflamma- some activation may lead to autoimmune, autoinflammatory, and metabolic disorders. Among the consequences of NLRP3 inflammasome activation is systemic chronic low-grade inflammation, a cardinal feature of obesity and insulin resistance. Understanding the mechanisms involved in the regulation of NLRP3 inflammasome in adipose tissue may help in the development of specific inhibitors for the treatment and prevention of obesity-mediated metabolic diseases. In this narrative review, the current understanding of NLRP3 inflammasome activation and regulation is highlighted, including its putative roles in adipose tissue dysfunction and insulin resistance. Specific inhibitors of NLRP3 inflammasome activation which can potentially be used to treat metabolic disorders are also discussed. Keywords: NLRP3 inflammasome; metabolic stress; insulin resistance; diabetes; obesity Citation: Wani, K.; AlHarthi, H.; Alghamdi, A.; Sabico, S.; Al-Daghri, N.M. Role of NLRP3 Inflammasome 1. -
Supplementary A
Genomic Analysis of the Immune Gene Repertoire of Amphioxus Reveals Extraordinary Innate Complexity and Diversity Supplementary A Content 1 TLR system....................................................................................................................................2 2 NLR system ...................................................................................................................................4 3 LRRIG genes .................................................................................................................................5 4 Other LRR-containing models.......................................................................................................6 5 Domain combinations in amphioxus C-type lectins ......................................................................8 References.........................................................................................................................................9 Table S1. Cross-species comparison of the immune-related protein domains................................10 Table S2. Information of 927 amphioxus CTL gene models containing single CTLD domain. ....11 Table S3. Grouping of the amphioxus DFD gene models based on their architectures..................12 Figure S1. Two structural types of TLR. ........................................................................................13 Figure S2. Phylogenetic analysis of amphioxus P-TLRs and all vertebrate TLR families.............14 Figure S3. Phylogenetic analysis of amphioxus TLRs -
Α Are Regulated by Heat Shock Protein 90
The Levels of Retinoic Acid-Inducible Gene I Are Regulated by Heat Shock Protein 90- α Tomoh Matsumiya, Tadaatsu Imaizumi, Hidemi Yoshida, Kei Satoh, Matthew K. Topham and Diana M. Stafforini This information is current as of October 2, 2021. J Immunol 2009; 182:2717-2725; ; doi: 10.4049/jimmunol.0802933 http://www.jimmunol.org/content/182/5/2717 Downloaded from References This article cites 44 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/182/5/2717.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 2, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Levels of Retinoic Acid-Inducible Gene I Are Regulated by Heat Shock Protein 90-␣1 Tomoh Matsumiya,*‡ Tadaatsu Imaizumi,‡ Hidemi Yoshida,‡ Kei Satoh,‡ Matthew K. Topham,*† and Diana M. Stafforini2*† Retinoic acid-inducible gene I (RIG-I) is an intracellular pattern recognition receptor that plays important roles during innate immune responses to viral dsRNAs. -
Post-Translational Regulation of Inflammasomes
OPEN Cellular & Molecular Immunology (2017) 14, 65–79 & 2017 CSI and USTC All rights reserved 2042-0226/17 www.nature.com/cmi REVIEW Post-translational regulation of inflammasomes Jie Yang1,2, Zhonghua Liu1 and Tsan Sam Xiao1 Inflammasomes play essential roles in immune protection against microbial infections. However, excessive inflammation is implicated in various human diseases, including autoinflammatory syndromes, diabetes, multiple sclerosis, cardiovascular disorders and neurodegenerative diseases. Therefore, precise regulation of inflammasome activities is critical for adequate immune protection while limiting collateral tissue damage. In this review, we focus on the emerging roles of post-translational modifications (PTMs) that regulate activation of the NLRP3, NLRP1, NLRC4, AIM2 and IFI16 inflammasomes. We anticipate that these types of PTMs will be identified in other types of and less well-characterized inflammasomes. Because these highly diverse and versatile PTMs shape distinct inflammatory responses in response to infections and tissue damage, targeting the enzymes involved in these PTMs will undoubtedly offer opportunities for precise modulation of inflammasome activities under various pathophysiological conditions. Cellular & Molecular Immunology (2017) 14, 65–79; doi:10.1038/cmi.2016.29; published online 27 June 2016 Keywords: inflammasome; phosphorylation; post-translational modifications; ubiquitination INTRODUCTION upstream sensor molecules through its PYD domain and The innate immune system relies on pattern recognition downstream -
Genetic Variant in 3' Untranslated Region of the Mouse Pycard Gene
bioRxiv preprint doi: https://doi.org/10.1101/2021.03.26.437184; this version posted March 26, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 2 3 Title: 4 Genetic Variant in 3’ Untranslated Region of the Mouse Pycard Gene Regulates Inflammasome 5 Activity 6 Running Title: 7 3’UTR SNP in Pycard regulates inflammasome activity 8 Authors: 9 Brian Ritchey1*, Qimin Hai1*, Juying Han1, John Barnard2, Jonathan D. Smith1,3 10 1Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic, 11 Cleveland, OH 44195 12 2Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 13 44195 14 3Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western 15 Reserve University, Cleveland, OH 44195 16 *, These authors contributed equally to this study. 17 Address correspondence to Jonathan D. Smith: email [email protected]; ORCID ID 0000-0002-0415-386X; 18 mailing address: Cleveland Clinic, Box NC-10, 9500 Euclid Avenue, Cleveland, OH 44195, USA. 19 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.03.26.437184; this version posted March 26, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 20 Abstract 21 Quantitative trait locus mapping for interleukin-1 release after inflammasome priming and activation 22 was performed on bone marrow-derived macrophages (BMDM) from an AKRxDBA/2 strain intercross. -
ATP-Binding and Hydrolysis in Inflammasome Activation
molecules Review ATP-Binding and Hydrolysis in Inflammasome Activation Christina F. Sandall, Bjoern K. Ziehr and Justin A. MacDonald * Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, Canada; [email protected] (C.F.S.); [email protected] (B.K.Z.) * Correspondence: [email protected]; Tel.: +1-403-210-8433 Academic Editor: Massimo Bertinaria Received: 15 September 2020; Accepted: 3 October 2020; Published: 7 October 2020 Abstract: The prototypical model for NOD-like receptor (NLR) inflammasome assembly includes nucleotide-dependent activation of the NLR downstream of pathogen- or danger-associated molecular pattern (PAMP or DAMP) recognition, followed by nucleation of hetero-oligomeric platforms that lie upstream of inflammatory responses associated with innate immunity. As members of the STAND ATPases, the NLRs are generally thought to share a similar model of ATP-dependent activation and effect. However, recent observations have challenged this paradigm to reveal novel and complex biochemical processes to discern NLRs from other STAND proteins. In this review, we highlight past findings that identify the regulatory importance of conserved ATP-binding and hydrolysis motifs within the nucleotide-binding NACHT domain of NLRs and explore recent breakthroughs that generate connections between NLR protein structure and function. Indeed, newly deposited NLR structures for NLRC4 and NLRP3 have provided unique perspectives on the ATP-dependency of inflammasome activation. Novel molecular dynamic simulations of NLRP3 examined the active site of ADP- and ATP-bound models. The findings support distinctions in nucleotide-binding domain topology with occupancy of ATP or ADP that are in turn disseminated on to the global protein structure. -
Inflammasome Activation and Regulation
Zheng et al. Cell Discovery (2020) 6:36 Cell Discovery https://doi.org/10.1038/s41421-020-0167-x www.nature.com/celldisc REVIEW ARTICLE Open Access Inflammasome activation and regulation: toward a better understanding of complex mechanisms Danping Zheng1,2,TimurLiwinski1,3 and Eran Elinav 1,4 Abstract Inflammasomes are cytoplasmic multiprotein complexes comprising a sensor protein, inflammatory caspases, and in some but not all cases an adapter protein connecting the two. They can be activated by a repertoire of endogenous and exogenous stimuli, leading to enzymatic activation of canonical caspase-1, noncanonical caspase-11 (or the equivalent caspase-4 and caspase-5 in humans) or caspase-8, resulting in secretion of IL-1β and IL-18, as well as apoptotic and pyroptotic cell death. Appropriate inflammasome activation is vital for the host to cope with foreign pathogens or tissue damage, while aberrant inflammasome activation can cause uncontrolled tissue responses that may contribute to various diseases, including autoinflammatory disorders, cardiometabolic diseases, cancer and neurodegenerative diseases. Therefore, it is imperative to maintain a fine balance between inflammasome activation and inhibition, which requires a fine-tuned regulation of inflammasome assembly and effector function. Recently, a growing body of studies have been focusing on delineating the structural and molecular mechanisms underlying the regulation of inflammasome signaling. In the present review, we summarize the most recent advances and remaining challenges in understanding the ordered inflammasome assembly and activation upon sensing of diverse stimuli, as well as the tight regulations of these processes. Furthermore, we review recent progress and challenges in translating inflammasome research into therapeutic tools, aimed at modifying inflammasome-regulated human diseases. -
Functional Screening of ¢Ve PYPAF Family Members Identi¢Es PYPAF5 As a Novel Regulator of NF-UB and Caspase-1
FEBS 26602 FEBS Letters 530 (2002) 73^78 Functional screening of ¢ve PYPAF family members identi¢es PYPAF5 as a novel regulator of NF-UB and caspase-1 Jill M.Grenier 1, Lin Wang1, Gulam A.Manji 2, Waan-Jeng Huang, Amal Al-Garawi, Roxanne Kelly, Adam Carlson, Sarah Merriam, Jose M.Lora, Michael Briskin, Peter S.DiStefano 3, John Bertinà Millennium Pharmaceuticals Inc., 75 Sidney Street, Cambridge, MA 02139, USA Received 22 August 2002; accepted 28 August 2002 First published online 26 September 2002 Edited by Veli-Pekka Lehto activates pro-caspase-9.Apaf-1 has a tripartite domain struc- Abstract PYRIN-containing Apaf-1-like proteins (PYPAFs) are a recently identi¢ed family of proteins thought to function ture consisting of an N-terminal caspase-recruitment domain in apoptotic and in£ammatory signaling pathways. PYPAF1 (CARD) that mediates recruitment of pro-caspase-9 to the and PYPAF7 proteins have been found to assemble with the apoptosome, a central nucleotide-binding site (NBS) domain, PYRIN^CARD protein ASC and coordinate the activation of and a C-terminal domain comprised of WD-40 repeats.The NF-UB and pro-caspase-1. To determine if other PYPAF family NBS domain mediates Apaf-1 oligomerization in the presence members function in pro-in£ammatory signaling pathways, we of dATP, whereas the WD-40 repeats function as binding sites screened ¢ve other PYPAF proteins (PYPAF2, PYPAF3, PY- for cytochrome c.Thus, Apaf-1 functions as a sensor-like PAF4, PYPAF5 and PYPAF6) for their ability to activate NF- molecule that signals apoptosis in response to the release of U B and pro-caspase-1. -
Blau Syndrome Polymorphisms in NOD2 Identify Nucleotide Hydrolysis and Helical Domain 1 As Signalling Regulators ⇑ Rhiannon Parkhouse A, Joseph P
FEBS Letters 588 (2014) 3382–3389 journal homepage: www.FEBSLetters.org Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators ⇑ Rhiannon Parkhouse a, Joseph P. Boyle a,b, Tom P. Monie a,b, a Department of Biochemistry, University of Cambridge, Cambridge, UK b Department of Veterinary Medicine, University of Cambridge, Cambridge, UK article info abstract Article history: Understanding how single nucleotide polymorphisms (SNPs) lead to disease at a molecular level Received 10 June 2014 provides a starting point for improved therapeutic intervention. SNPs in the innate immune recep- Revised 23 July 2014 tor nucleotide oligomerisation domain 2 (NOD2) can cause the inflammatory disorders Blau Syn- Accepted 23 July 2014 drome (BS) and early onset sarcoidosis (EOS) through receptor hyperactivation. Here, we show Available online 2 August 2014 that these polymorphisms cluster into two primary locations: the ATP/Mg2+-binding site and helical Edited by Renee Tsolis domain 1. Polymorphisms in these two locations may consequently dysregulate ATP hydrolysis and NOD2 autoinhibition, respectively. Complementary mutations in NOD1 did not mirror the NOD2 phenotype, which indicates that NOD1 and NOD2 are activated and regulated by distinct methods. Keywords: Nucleotide-binding, leucine-rich repeat Ó 2014 The Authors. Published by Elsevier B.V. on behalf of the Federation of European Biochemical containing receptor Societies. This is an open access article under the CC BY license (http://creativecommons.org/licenses/ -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase